Didi Wan

机构：Zhengzhou University

发表论文 8 篇 · 总被引 44 次 · h-index 3

代表论文

• GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis (2024 · Discover Oncology · 被引 19)
• Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer (2020 · Frontiers in Cell and Developmental Biology · 被引 19)
• Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types (2024 · Cancer Insight · 被引 3)
• A novel phenolic propanediamine moiety-based lung-targeting therapy for asthma (2018 · Drug Delivery · 被引 2)
• Structural and functional constraints on spike activation and host protease utilization limit cell entry of SARS-CoV-2-related bat coronaviruses (2025 · Journal of Virology · 被引 1)
• Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer (2022 · Frontiers in Cell and Developmental Biology)